American Association for the Advancement of Science, Science Advances, 27(6), 2020
DOI: 10.1126/sciadv.aba8564
Export citation
Search in Google Scholar
Full text: Download
A trispecific natural killer cell engager platform has been successfully engineered for EGFR-targeted chemoimmunotherapy.